GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹137 Cr | ₹122 Cr | ₹19 Cr | ₹23 Cr | ₹17 Cr |
What is the latest Net Current Assets ratio of GENNEX LABORATORIES ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹137 Cr |
| Mar2024 | ₹122 Cr |
| Mar2023 | ₹19 Cr |
| Mar2022 | ₹23 Cr |
| Mar2021 | ₹17 Cr |
How is Net Current Assets of GENNEX LABORATORIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹137 Cr | 12.40 | |
| Mar2024 | ₹122 Cr | 533.85 | |
| Mar2023 | ₹19 Cr | -16.56 | |
| Mar2022 | ₹23 Cr | 32.37 | |
| Mar2021 | ₹17 Cr | - | |
Compare Net Current Assets of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹329.4 Cr | -4.4% | 4% | -22.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -4.4% |
4% |
-22.1% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses